Sell-Off in Biotech ETFs Could Be a Temporary Setback

Biotechnology exchange traded funds are on a three-day sell-off after falling short of its 52-week high Friday, but the sector can still find its footing. The he iShares Nasdaq Biotech (NasdaqGM: IBB) has declined 7.5% in the past three sessions, Market Vectors Biotech ETF (NYSEArca: BBH) fell 8.0%...